{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:05:43Z","timestamp":1773083143857,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,19]]},"DOI":"10.1097\/wnr.0b013e3282f1ab33","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T23:40:24Z","timestamp":1236123624000},"page":"1867-1870","source":"Crossref","is-referenced-by-count":25,"title":["Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease"],"prefix":"10.1097","volume":"18","author":[{"given":"Masahiko","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Urashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210201","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000215437.80053.d0","article-title":"Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"66","author":"Suchowersky","year":"2006","journal-title":"Neurology"},{"key":"R2-23-20210201","first-page":"349","article-title":"Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"R3-23-20210201","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","article-title":"Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease","volume":"18","author":"Taki","year":"2004","journal-title":"Ann Nucl Med"},{"key":"R4-23-20210201","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","article-title":"Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease","volume":"18","author":"Courbon","year":"2003","journal-title":"Mov Disord"},{"key":"R5-23-20210201","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","article-title":"Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease","volume":"76","author":"Nagayama","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-23-20210201","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"R7-23-20210201","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson's disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch Neurol"},{"key":"R8-23-20210201","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.20384","article-title":"Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report","volume":"20","author":"Suzuki","year":"2005","journal-title":"Mov Disord"},{"key":"R9-23-20210201","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/archneur.59.11.1724","article-title":"Predicting motor decline and disability in Parkinson disease: a systematic review","volume":"59","author":"Marras","year":"2002","journal-title":"Arch Neurol"},{"key":"R10-23-20210201","first-page":"153","article-title":"Recent developments in Parkinson's disease","author":"Fahn","year":"1987"},{"key":"R11-23-20210201","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"key":"R12-23-20210201","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02292766","article-title":"The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes","volume":"11","author":"Braune","year":"2001","journal-title":"Clin Auton Res"},{"key":"R13-23-20210201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","article-title":"Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD","volume":"220","author":"Saiki","year":"2004","journal-title":"J Neurol Sci"},{"key":"R14-23-20210201","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.74.4.423","article-title":"Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease","volume":"74","author":"Hamada","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-23-20210201","first-page":"1099","article-title":"Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies","volume":"47","author":"Kashihara","year":"2006","journal-title":"J Nucl Med"},{"key":"R16-23-20210201","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.35.4.522","article-title":"The heterogeneity of Parkinson's disease: clinical and prognostic implications","volume":"35","author":"Zetusky","year":"1985","journal-title":"Neurology"},{"key":"R17-23-20210201","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/01.wnl.0000183359.50822.f2","article-title":"Progression of motor impairment and disability in Parkinson disease: a population-based study","volume":"65","author":"Alves","year":"2005","journal-title":"Neurology"},{"key":"R18-23-20210201","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.21499","article-title":"Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease","volume":"22","author":"Spiegel","year":"2007","journal-title":"Mov Disord"},{"key":"R19-23-20210201","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","article-title":"FP-CIT and MIBG scintigraphy in early Parkinson's disease","volume":"20","author":"Spiegel","year":"2005","journal-title":"Mov Disord"}],"container-title":["NeuroReport"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001756-200711190-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:00:43Z","timestamp":1618279243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001756-200711190-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,19]]},"references-count":19,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnr.0b013e3282f1ab33","relation":{},"ISSN":["0959-4965"],"issn-type":[{"value":"0959-4965","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11,19]]}}}